Weight Loss
GLP-1 Weight Loss Program
A physician-guided weight loss program built around GLP-1 medications such as semaglutide and tirzepatide. Your licensed provider evaluates your health history and, if appropriate, prescribes a treatment plan tailored to your metabolism and goals — with ongoing dose support, side-effect management, and progress tracking.
Prescriptions are issued only after an online consultation with an independent licensed healthcare provider, who will determine if treatment is appropriate for you. Not all patients will qualify.
Benefits
What this therapy may support
- Clinically studied medications shown to support 15–20% average body weight reduction over one year when combined with diet and exercise
- Reduced appetite and quieter food noise
- Provider-guided dose titration and side-effect management
- Free expedited, discreet shipping every month
Individual results vary. Average weight loss figures are based on published clinical trials of FDA-approved GLP-1 medications combined with diet and exercise; they are not a guarantee of your results.
Compounded medications are prepared by state-licensed compounding pharmacies for specific patient needs based on a valid prescription. Compounded medications are not approved by the FDA, and the FDA does not review them for safety, effectiveness, or quality before they are marketed. Compounded medications are not the same as, and are not generic versions of, any FDA-approved medication. Quenva does not manufacture or compound any medication. Actual product packaging may differ from imagery shown.
Plan options
Monthly plan
Cancel anytime · FSA/HSA eligible
$299/mo
3-month plan
Billed quarterly · FSA/HSA eligible
$249/mo
First month: $199
New patient introductory pricing, applied automatically.
Price includes provider visit, prescribed medication if appropriate, ongoing support, and free shipping.
Your starting point
See what's possible for your body
Free tool
Check your BMI
Enter your height and weight below.
BMI doesn't directly measure body fat and may not reflect health for all body types. It does not determine eligibility — a licensed provider must evaluate your health history to decide if treatment is right for you.
Weight loss projection
Select your current weight
You could lose
33 lbs
based on an average 15% body weight reduction in clinical trials of FDA-approved GLP-1s*
Individual results vary. Average weight loss figures are based on published clinical trials of FDA-approved GLP-1 medications combined with diet and exercise; they are not a guarantee of your results.
Important Safety Information — GLP-1 Medications
WARNING — RISK OF THYROID C-CELL TUMORS: In rodents, GLP-1 receptor agonists caused thyroid C-cell tumors. It is unknown whether these medications cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or any family member has a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use if you have
- Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
- Known hypersensitivity to semaglutide, tirzepatide, or product components
- Pregnancy, planned pregnancy, or breastfeeding
- History of pancreatitis (use requires careful provider evaluation)
Common side effects
The most common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite, particularly when starting therapy or increasing dose.
Serious risks
Seek immediate medical attention for symptoms of pancreatitis (severe abdominal pain that may radiate to the back), gallbladder problems, severe hypoglycemia (especially with diabetes medications), kidney injury from dehydration, or serious allergic reaction. Stop use and contact your provider if you experience vision changes.
This information is not comprehensive. Your provider will review complete safety information with you before prescribing. Report side effects to your care team promptly, and call 911 for emergencies. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective owners. Quenva is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any pharmaceutical manufacturer. References to brand-name medications are for informational purposes only.
